University of Oulu

Peeter Karihtala, Katja Porvari, Ylermi Soini, and Kirsi-Maria Haapasaari, “Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2696071, 8 pages, 2017. doi:10.1155/2017/2696071

Redox regulating enzymes and connected MicroRNA regulators have prognostic value in classical Hodgkin Lymphomas

Saved in:
Author: Karihtala, Peeter1; Porvari, Katja2; Soini, Ylermi2;
Organizations: 1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
2Department of Pathology, Medical Research Center Oulu,Oulu University Hospital and University of Oulu,Oulu, Finland
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 1.4 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe201705226709
Language: English
Published: Hindawi Publishing Corporation, 2017
Publish Date: 2017-05-22
Description:

Abstract

There are no previous studies assessing the microRNAs that regulate antioxidant enzymes in Hodgkin lymphomas (HLs). We determined the mRNA levels of redox regulating enzymes peroxiredoxins (PRDXs) I–III, manganese superoxide dismutase (MnSOD), nuclear factor erythroid-derived 2-like 2 (Nrf2), and Kelch-like ECH-associated protein 1 (Keap1) from a carefully collected set of 41 classical HL patients before receiving any treatments. The levels of redoxmiRs, miRNAs known to regulate the above-mentioned enzymes, were also assessed, along with CD3, CD20, and CD30 protein expression. RNAs were isolated from freshly frozen lymph node samples and the expression levels were analyzed by qPCR. mir23b correlated inversely with CD3 and CD20 expressions (𝑝 = 0.00076; 𝑟 = −0.523 and 𝑝 = 0.0012; 𝑟 = −0.507) and miR144 with CD3, CD20, and CD30 (𝑝 = 0.030; 𝑟 = −0.352, 𝑝 = 0.041; 𝑟 = −0.333 and 𝑝 = 0.0032; 𝑟 = −0.47, resp.). High MnSOD mRNA levels associated with poor HL-specific outcome in the patients with advanced disease (𝑝 = 0.045) and high miR-122 levels associated with worse HL-specific survival in the whole patient population (𝑝 = 0.015). When standardized according to the CD30 expression, high miR212 and miR510 predicted worse relapse-free survival (𝑝 = 0.049 and 𝑝 = 0.0058, resp.). In conclusion, several redoxmiRs and redox regulating enzyme mRNA levels associate with aggressive disease outcome and may also produce prognostic information in classical HL.

see all

Series: Oxidative medicine and cellular longevity
ISSN: 1942-0900
ISSN-E: 1942-0994
ISSN-L: 1942-0900
Volume: 2017
Article number: 2696071
DOI: 10.1155/2017/2696071
OADOI: https://oadoi.org/10.1155/2017/2696071
Type of Publication: A1 Journal article – refereed
Field of Science: 3122 Cancers
1182 Biochemistry, cell and molecular biology
Subjects:
Copyright information: Copyright © 2017 Peeter Karihtala et al. This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  https://creativecommons.org/licenses/by/4.0/